Romosozumab(anti-sclerostin)

Romosozumab is a monoclonal antibody that binds to sclerostin (an inhibitor of the Wingless-related integration site (Wnt) signaling pathway). It is a new osteoanabolic drug, that simultaneously increases bone formation and decreases bone resorption.

• Supplier: Selleck Chemicals
• Product #: A2050
• Sku #: A2050-1mg